Presented at the 3rd Meeting on Clinical Measurement and New Drug Development, Royal Society of Edinburgh, 13–14 June 2001.
Pharmacogenetics and the future of medical practice
Article first published online: 4 SEP 2002
British Journal of Clinical Pharmacology
Volume 54, Issue 2, pages 221–230, August 2002
How to Cite
Lindpaintner, K. (2002), Pharmacogenetics and the future of medical practice. British Journal of Clinical Pharmacology, 54: 221–230. doi: 10.1046/j.1365-2125.2002.01630.x
- Issue published online: 4 SEP 2002
- Article first published online: 4 SEP 2002
Pharmacogenetic approaches are widely expected to bring about a “revolution” in medicine. While the application of molecular genetic approaches to disease research will provide us with new opportunities for progressively more targeted and, hopefully, more effective treatments, these developments will be evolutionary in nature and will, for their realization, still require the painstaking process that discovering and developing a new drug entails. It is also quintessential for the realization of these promises that we support a more rational understanding and more realistic expectations in the public at large through dialogue and information.